SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-001139
Filing Date
2024-01-04
Accepted
2024-01-04 07:00:28
Documents
12
Period of Report
2024-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332524d1_8k.htm   iXBRL 8-K 32431
  Complete submission text file 0001104659-24-001139.txt   208355

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rytm-20240104.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20240104_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20240104_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2332524d1_8k_htm.xml XML 3320
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 24509737
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)